Clinical Trials Directory

Trials / Completed

CompletedNCT06365255

National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
1,344 (actual)
Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres. In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres.

Conditions

Interventions

TypeNameDescription
OTHERquestionnairesfilling in questionnaires

Timeline

Start date
2023-01-17
Primary completion
2024-02-28
Completion
2024-02-28
First posted
2024-04-15
Last updated
2024-04-17

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06365255. Inclusion in this directory is not an endorsement.